GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key ...

UCLA investigators present the latest radiotherapy research at the American Society for Radiation Oncology annual meeting ...

Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.

September is Blood Cancer Awareness Month, and recent weeks have brought major changes for people with blood cancers. In August, the FDA approved three treatments: Zenbexus (iberdomide) for relapsed ...

Conversations about cancer research are tough for anyone who has ever been diagnosed, treated, or lost someone to the disease ...

Researchers at The University of Texas MD Anderson Cancer Center have traced how off-the-shelf chimeric antigen receptor (CAR ...

Approved CD20×CD3 bispecifics (epcoritamab, glofitamab, mosunetuzumab) deliver meaningful ORR/CR in heavily pretreated DLBCL, but PFS remains modest, motivating combination strategies.

For patients with early-stage lung cancer who cannot undergo surgery, precision radiation therapy is the main curative-intent ...

Many cancer treatments work by exploiting weaknesses in tumor cells, overwhelming their ability to survive, repair damage or continue growing. Yet some cancer cells manage to survive treatment. A new ...